LambdaVision sets sights on artificial retina
LambdaVision’s signature product — an artificial retina that could change the lives of thousands with degenerative eye diseases — is under development aboard the International...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
LambdaVision’s signature product — an artificial retina that could change the lives of thousands with degenerative eye diseases — is under development aboard the International...
New data show that migraine patients treated with Biohaven’s Nurtec ODT decreased their use of opioids. “Results demonstrate a clinically meaningful reduction in opioid use in...
Yale has announced an ambitious new initiative to support and expand innovation and entrepreneurship across the university and throughout the greater New Haven region. Yale Ventures will...
Bioasis has entered into a research collaboration with Janssen Biotech, one of the pharmaceutical companies of Johnson & Johnson. Under the terms of the agreement, Janssen...
As a high-tech enterprise, Sino Biological specializes in the research, development, production and sales of biological reagents such as recombinant proteins, antibodies, genes and culture media. The...
Stamford-based Sema4, working in partnership with researchers from the Icahn School of Medicine at Mount Sinai in New York City, have published a study in Nature...
New Haven Promise builds a college-going, career, and civic-launch culture throughout the city of New Haven in which students in the public schools aspire to attend...
Alexion, AstraZeneca’s Rare Disease group, plans to expand its presence in New Haven with space at the new bioscience tower currently under construction at 101...
The FDA has approved a drug from New Haven-based BioXcel Therapeutics for the treatment of agitation associated with schizophrenia or bipolar disorder in adults. The FDA ruled that...